We are a dedicated team aiming to give type 2 diabetes patients back their health with our revolutionary insulin independent treatment

A global challenge with a simple solution

Our proprietary insulin independent solution can help type 2 diabetes (T2D) patients back to a healthy life. T2D patients don’t need to be restricted by their diagnosis. With the Atrogi solution, they can once again lead healthy lives.

Insulin independent – to give you the conditions needed to lead a healthy life

Your choice – you need to want it, the treatment will help you but your choices are key

The challenge

1 in 11 people are diagnosed with diabetes. The treatments available today are based on old discoveries leaving many patients short of accepted treatment goals. We have a solution for this with our innovative, insulin independent oral solution.

Our solution

We have discovered an unprecedented insulin independent approach to treat T2D. This will allow for a unique mode of action separating desired effect from side effects. This means minimal side effects for the patients, and a healthier life!

Patent granted Patent granted in USA One of Atrogis patent application was granted in the US (US 9,784,726). The patent describes inventions useful for [...]

“With 20 years of research behind me I can say the one constant throughout the years has been curiosity. My drive and passion for solving compartmental problems that fit into a whole and ultimately be administered into a human have always been fueled by my enormous curiosity.”

Tore Bengtsson, Founder and Chief Scientific Officer

Strategic Partners

Discover The Future

We are a multi-disciplinary team committed to focused and efficient drug development